Bristol-Myers Squibb


Bristol-Myers Squibb Stock Quote
$53.03 $0.61 1.2%
BATS BZX Real Time Price as of October 18, 2019, 4:00 p.m. EDT View Interactive BMY Charts

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

News & Analysis: Bristol-Myers Squibb

The Fool has written over 1000 articles on Bristol-Myers Squibb.


Market Moves



What Happened in the Stock Market Today

Bristol-Myers Squibb and Celgene made a deal to sell a blockbuster drug to Amgen, and Disney and Target are forming a retail collaboration.

3 Cancer Treatment Stocks to Buy Right Now

Cancer is one of the toughest diseases to fight, and these companies are playing a great role in helping people combat it.

5 Top Cancer-Fighting Stocks to Buy Now

Each of these healthcare companies takes a different approach to fighting cancer, but all have what it takes to be long-term winners in your portfolio.

Interactive Chart